Global Clinical Chemistry Analyzers Market 2017-2021
About Clinical Chemistry Analyzers
Clinical chemistry analyzers are used for the analysis of samples such as blood, serum, and urine for the detection of analytes. These analyzers are used to detect and measure protein, enzyme, and electrolyte levels present in the sample. The measurement is based on the techniques such as photometric and colorimetric testing, potentiometry, and agglutination.
Technavio’s analysts forecast the global clinical chemistry analyzers market to grow at a CAGR of 2.24% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global clinical chemistry analyzers market for 2017-2021. To calculate the market size, the report considers the new installations, sales, value, and replacement of clinical chemistry analyzers market.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Clinical Chemistry Analyzers Market 2017-2021
Technavio recognizes the following companies as the key players in the global clinical chemistry analyzers market: Abbott Laboratories, F. Hoffmann-La Roche, and Thermo Fisher Scientific.
Other Prominent Vendors in the market are: Danaher, Analytik Jena, BioSystems Diagnostics, DiaSys Diagnostic Systems, Diatron, EKF Diagnostics, ELITechGroup, HORIBA, Randox Laboratories, SFRI, and Shenzhen Mindray Bio-Medical Electronics.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is focus on fully automated clinical chemistry analyzers. In the last few years, clinical chemistry analyzers have been undergoing major changes in design and function. Typically, the POC monitoring of anticoagulation is done in outpatient anticoagulation clinics, cardiac surgery units, intensive care units (ICUs), and dialysis units with the help of different technologies. There are fully automated clinical chemistry analyzers available in the market that can perform functions such as recognition of sample and reagent bottles, tube sampling, cap piercing, automatic re-run, and dilution.”
According to the report, one of the major drivers for this market is rising demand for automation and integration of multiple processes. Clinical laboratories rely on progressing levels of automation to solve persistent challenges that include lack of skilled personnel, pressures to maintain cost while increasing productivity, and errors associated with manual processes.
Further, the report states that one of the major factors hindering the growth of this market is limited laboratory budgets and reimbursements. The reimbursement policies for diagnostic testing are not constant across regions, and they are witnessing a downward trend. The hospitals, clinics, and diagnostic laboratories are the primary end-users that are forced to reduce their expenditure on clinical chemistry analyzers to achieve either break even or profitable revenue. The limited number of professionals at clinical laboratories and increasing incidence of lost health insurance cards have forced clinical laboratories to find alternative ways to maintain revenue despite limited capacity and testing volumes.
Abbott Laboratories, F. Hoffmann-La Roche, Thermo Fisher Scientific, Danaher, Analytik Jena, BioSystems Diagnostics, DiaSys Diagnostic Systems, Diatron, EKF Diagnostics, ELITechGroup, HORIBA, Randox Laboratories, SFRI, and Shenzhen Mindray Bio-Medical Electronics.